The short version of Angiotensin IV fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-24. Anything still debated is marked as such rather than presented as settled.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide analog | Structural features include amino acid residues and a hexanoic acid group. |
| Common synonyms | PNB-0408; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Names vary by source and should be verified. |
| Origin | Angiotensin IV research | Developed as a modified analog in academic laboratories. |
| Primary research focus | Synaptic growth and cognition | Studied mainly in cultured neurons and rodent models. |
| Regulatory status | Not approved as a drug | No accepted human therapeutic or supplement status. |
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Penile measurements vary, with studies that rely on self-measurement reporting a significantly higher average size than those which rely on measurements taken by health professionals. A 2015 systematic review of 15,521 men in which the subjects were measured by health professionals showed that the average length of an erect human penis is 13.12 cm (5.17 inches) long, while the average circumference of an erect human penis is 11.66 cm (4.59 inches). Among all primates, the human penis is the largest in girth, but is comparable to the chimpanzee penis and the penises of certain other primates in length. Penis size is affected by genetics, but also by environmental factors such as fertility medications and chemical/pollution exposure.
== History == Pseudoephedrine, along with ephedrine, occurs naturally in ephedra. This herb has been used for thousands of years in traditional Chinese medicine. Pseudoephedrine was first isolated and characterized in 1889 by the German chemists Ladenburg and Oelschlägel, who used a sample that had been isolated from Ephedra vulgaris by the Merck pharmaceutical corporation of Darmstadt, Germany. It was first synthesized in the 1920s in Japan. Subsequently, pseudoephedrine was introduced for medical use as a decongestant.
== Applications == Polonium-based sources of alpha particles were produced in the former Soviet Union. Such sources were applied for measuring the thickness of industrial coatings via attenuation of alpha radiation. Because of intense alpha radiation, a one-gram sample of 210Po will spontaneously heat up to above 500 °C (932 °F) generating about 140 watts of power. Therefore, 210Po is used as an atomic heat source to power radioisotope thermoelectric generators via thermoelectric materials. For example, 210Po heat sources were used in the Lunokhod 1 (1970) and Lunokhod 2 (1973) Moon rovers to keep their internal components warm during the lunar nights, as well as the Kosmos 84 and 90 satellites (1965). The alpha particles emitted by polonium can be converted to neutrons using beryllium oxide, at a rate of 93 neutrons per million alpha particles. Po-BeO mixtures are used as passive neutron sources with a gamma-ray-to-neutron production ratio of 1.13 ± 0.05, lower than for nuclear fission-based neutron sources. Examples of Po-BeO mixtures or alloys used as neutron sources are a neutron trigger or initiator for nuclear weapons and for inspections of oil wells. About 1500 sources of this type, with an individual activity of 1,850 Ci (68 TBq), had been used annually in the Soviet Union. Polonium was also part of brushes or more complex tools that eliminate static charges in photographic plates, textile mills, paper rolls, sheet plastics, and on substrates (such as automotive) prior to the application of coatings.
Many physicians operate by the World Professional Association of Transgender Health (WPATH) Standards of Care (SoC) model and require psychotherapy and a letter of recommendation from a psychotherapist in order for a transgender person to obtain hormone therapy. Other physicians operate by an informed consent model and have no requirements for transgender hormone therapy aside from consent. Medications used in transgender hormone therapy are also sold without a prescription on the Internet by unregulated online pharmacies, and some transgender women purchase these medications and treat themselves using a do-it-yourself (DIY) or self-medication approach. One reason that many transgender people turn to DIY hormone therapy is due to long waiting lists of up to years for standard physician-based hormone therapy in some parts of the world such as the United Kingdom, as well as due to the often high costs of seeing a physician and the restrictive criteria that make some ineligible for treatment, or simply medical malpractice by physicians that are not adequately trained. The accessibility of transgender hormone therapy differs throughout the world and throughout individual countries.
Sources: en.wikipedia.org
=== Age-related macular degeneration === A Cochrane review concluded that there were no changes seen for risk of developing age-related macular degeneration (AMD) from long-term vitamin E supplementation and that supplementation may slightly increase the chances of developing late AMD.
For services to Aviation. Elsie Macpherson. For services to Mentally Ill People. Maureen S. Macmillan, Chairman, City of Edinburgh Children's Panel Advisory Committee. For services to Young People. Stuart Macredie, lately Headteacher, St Albans Junior and Infant School, Wickersley, Rotherham. For services to Education. The Reverend Robert James Magee. For services to Community Relations. Alan Roderick Males. For services to Architecture. Patricia Anne Mansfield. For services to the community in Leicester. Constance May Marcroft. For services to Deaf People in Sheffield. Leslie George Mardell, Administrative Officer, London Fire and Civil Defence Authority. For services to the Fire Service. Samuel Steele Marsden. For services to Agriculture. Derek Marshall, Chief Executive, South Humber Business Advice Centre Ltd. For services to Business. Keith John Martin. For political and public service Rosemary Elizabeth Massey, Office Manager, Lord Chancellor's Department. Stanley Thomas Massey. For services to the community in Havant, Hampshire. Carole Kathleen Masters, Higher Executive Officer, Department of Social Security. William James McAlpine. For services to Scouting. Joan McCallion, Typist, Ministry of Defence. Rachel McClean. For services to Training. Isa McComb. For services to Housing. William Rae McCrindle, Chairman, McCrindle Group. For services to the Engineering Industry. David McCubbin, Compliance Manager, Board of Inland Revenue. Norman Charles John McElroy. For services to the Police. William McGowan, Farmer. For services to the Cattle Industry in Fife.
Gynecomastia induced by spironolactone usually regresses after a few weeks following discontinuation of the medication. However, after a sufficient duration of gynecomastia being present (e.g., one year), hyalinization and fibrosis of the tissue occurs and drug-induced gynecomastia may become irreversible.
Sources: en.wikipedia.org
== Early life == Rosanna Jeanne Reardon was born on June 8, 1985, in Seattle, Washington, where she was raised alongside her younger sister Molly Lu. She is of Italian, Croatian, German, and Irish ancestry. She was baptized Catholic. Throughout her childhood, she was known by friends and family as a "nerdy", "awkward" kid, and she struggled with dyslexia and ADHD in school. She originally wanted to become an actress, and after attending West Seattle High School and Pacific Lutheran University, she moved to Los Angeles to pursue acting. Prior to her YouTube career, Pansino worked as a teacher in China and as a Methodist church secretary. Pansino's interest in cooking was inspired by her father and grandmother, and she stated in 2014 that "...baking has always been a hobby of mine. I have always loved being creative with my food and making themed sweets for my friends."
Bradford East MP Imran Hussain resigns as Shadow Minister for the New Deal for Working People from the opposition frontbench citing Keir Starmer's response to the Gaza war. 8 November Possession of nitrous oxide, commonly known as "laughing gas" or "NOS", is categorised as a Class C drug, making its possession illegal in the UK. Sunak says he will hold the Commissioner of the Metropolitan Police "accountable" over a pro-Palestinian march planned for Armistice Day, and meets with Sir Mark Rowley to discuss the demonstration. Members of the National Union of Rail, Maritime and Transport Workers are to vote on a revised pay offer and guarantee of job security that could end the railway strikes. The Mounjaro injection for treating obesity is approved for use in the UK by the Medicines and Healthcare products Regulatory Agency. 9 November Home Secretary Suella Braverman faces questions about her future after writing an article for The Times questioning the impartiality of the police over the way they deal with demonstrations, claiming that aggressive right-wing protesters are "rightly met with a stern response", while "pro-Palestinian mobs" are "largely ignored". The article was not cleared by Downing Street, while she ignored suggested changes to the piece made by officials. Data from NHS England shows waiting lists in England reached a record high in September 2023, with 7.77 million people waiting for treatment in England, including over a million on more than one waiting list.
== External links == Shodex Worldwide and Asia general website Shodex North and Latin America website Shodex Europe, Middle East, Africa website Showa Denko Develops New Shodex™ Analytical Column Resonac Website about Shodex HPLC columns
The experiment showed that C-1 of glycine was found almost exclusively in the glycyl portion of hadacidin while formate, the 3-carbon of serine, and the 2-carbon of glycine were incorporated into both the glycyl and formyl portions of the hydroxamate. N-Hydroxyglycine was incorporated into hadacidin at a rate equal to that for glycine in 3-hr periods and to a much greater extent in longer time periods. N-Hydroxyglycine, but not glycine, brought about a net stimulation of hydroxamate production. Nitroacetic acid, glyoxylic acid oxime, and formylglycine were not rapidly incorporated into hadacidin. Experiments showed that the hydroxylamino oxygen atom of hadacidin is derived from oxygen gas rather than water. The experimental results are consistent with the hypothesis that the biosynthesis of hadacidin occurs by N-oxygenation of glycine to yield N-hydroxyglycine followed by N-formylation to yield the hydroxamate.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide-like compound studied primarily in preclinical models. It is often classified as an angiotensin IV analog and has been investigated for effects on neuronal connectivity. It is not an approved drug or dietary supplement.
The exact mechanism is uncertain. Some research proposes activation of hepatocyte growth factor/c-Met signaling, while other evidence implicates insulin-regulated aminopeptidase. Multiple pathways may contribute, depending on the experimental system.
Published large-scale human trials are lacking. Most available data come from cell cultures and animal studies. As a result, human safety, appropriate dosing, and clinical effectiveness are not established.
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.